CRISCUOLO, EMANUELE
CRISCUOLO, EMANUELE
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.003 secondi).
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1
2023-12-02 Criscuolo, E; De Sciscio, Ml; De Cristofaro, A; Nicoara, C; Maccarrone, M; Fezza, F
Fatty acid amide hydrolase, anandamide, and neurological diseases
2023-01-01 Fezza, F; Criscuolo, E; De Sciscio, Ml; Maccarrone, M
Quantitation of oxidized and reduced albumin in mammals. An intriguing analytical question
2024-05-13 Gambardella, G; Notari, S; Criscuolo, E; Lai, O; Nardoni, A; Massoud, R; Micheli, L; Bocedi, A; Ricci, G
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 2-dic-2023 | Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 | Criscuolo, E; De Sciscio, Ml; De Cristofaro, A; Nicoara, C; Maccarrone, M; Fezza, F | Articolo su rivista | |
| 1-gen-2023 | Fatty acid amide hydrolase, anandamide, and neurological diseases | Fezza, F; Criscuolo, E; De Sciscio, Ml; Maccarrone, M | Contributo in libro | |
| 13-mag-2024 | Quantitation of oxidized and reduced albumin in mammals. An intriguing analytical question | Gambardella, G; Notari, S; Criscuolo, E; Lai, O; Nardoni, A; Massoud, R; Micheli, L; Bocedi, A; Ricci, G | Articolo su rivista |